PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   


Catalogue
Number
Product Order number / Unit

9831 DOTA-Lanreotide acetate 9831.0001: 1 mg per vial
9831.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.

 
Precursor for radiolabelled DOTA-Lanreotide
Ligand for somatostatin receptors
Molar Mass: 1481.7
C70H95N15O17S2
[213187-44-1] (net peptide)
Colourless to off-white freeze-dried solid packaged in screw cap vials.
Purity: ≥ 95 %
Certificates:
CoA; MS (identity); HPLC (purity)
Chemical Name:
Sequence: DOTA-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, cyclic disulfide
DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-
Supplied as acetate salt
Synonymes:
DOTA-BIM-23014; CA index name: L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl] -D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7) disulfide
Literature:
Smith-Jones P.M. et al. DOTA-Lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 1999, 140, 5136 - 5148.
Banerjee S. et al. 177Lu-DOTA-lanreotide: a novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 2004, 31, 753-759.
date of product catalogue issue: 10 May 2017

 
 
 

  PDF file       product list       home page       search       email       legal notice